Breaking News Instant updates and real-time market news.

PDD

Pinduoduo

$23.37

-0.36 (-1.52%)

, ROKU

Roku

$65.47

-0.9 (-1.36%)

10:04
05/07/19
05/07
10:04
05/07/19
10:04

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pinduoduo (PDD) initiated with a Hold at 86 Research. 2. Roku (ROKU) initiated with an Overweight at Stephens. 3. Jumia Technologies (JMIA) initiated with a Hold at Stifel, with a Hold at Berenberg, with a Market Perform at Raymond James, with an Underweight at Morgan Stanley and with a Market Perform at William Blair. 4. Texas Instruments (TXN) initiated with a Neutral at Nomura Instinet. 5. TSMC (TSM) initiated with a Buy at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

PDD

Pinduoduo

$23.37

-0.36 (-1.52%)

ROKU

Roku

$65.47

-0.9 (-1.36%)

JMIA

Jumia Technologies

$35.31

-1.19 (-3.26%)

TXN

Texas Instruments

$113.70

-0.71 (-0.62%)

TSM

TSMC

$43.67

-0.1 (-0.23%)

  • 08

    May

  • 20

    May

  • 22

    May

  • 29

    May

PDD Pinduoduo
$23.37

-0.36 (-1.52%)

05/07/19
EGHT
05/07/19
INITIATION
EGHT
Hold
Pinduoduo initiated with a Hold at 86 Research
86 Research analyst Xiaoyan Wang initiated Pinduoduo with a Hold saying he is "wary of competition" from Taobao.
04/16/19
KEYB
04/16/19
INITIATION
KEYB
Overweight
Pinduoduo initiated with an Overweight at KeyBanc
04/16/19
KEYB
04/16/19
INITIATION
Target $23
KEYB
Overweight
Pinduoduo initiated with an Overweight at KeyBanc
KeyBanc initiated Pinduoduo with an Overweight rating and a price target of $23.
04/17/19
04/17/19
INITIATION
Target $32

Overweight
KeyBanc views Pinduoduo as 'solid investment,' initiates with Overweight
As previously reported, KeyBanc analyst Hans Chung started coverage of Pinduoduo with an Overweight rating and a $32 price target. Despite controversy on the company's room for growth and profitability potential, the analyst views Pinduoduo as a solid investment given that it is the second largest e-commerce platform in China by customer and merchant scales, which presents sizeable monetization potential, and its social team-purchase model that helps itself capitalize on value created by streamlining the retail value chain.
ROKU Roku
$65.47

-0.9 (-1.36%)

05/01/19
VERF
05/01/19
UPGRADE
VERF
Hold
Roku upgraded to Mixed from Negative at Vertical Group
05/06/19
SPHN
05/06/19
INITIATION
Target $84
SPHN
Overweight
Roku initiated with an Overweight, $84 price target at Stephens
Stephens analyst Kyle Evans started Roku with an Overweight rating and $84 price target. The stock is likely to remain volatile, but weakness should be used as buying opportunities, Evans tells investors in a research note. He likes Roku's long-term industry position as an "independent, branded, embedded and capital-light player" at the nexus between smart TVs and an "increasingly fragmented" streaming video landscape. Evans views the company as well positioned to grow users, engagement and average revenue per user. Roku shares closed the trading day up 73c to $65.75.
04/22/19
SUSQ
04/22/19
INITIATION
Target $80
SUSQ
Positive
Roku initiated with a Positive at Susquehanna
Susquehanna analyst Shyam Patil initiated Roku with a Positive and $80 price target.
04/23/19
04/23/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Roku (ROKU) initiated with a Positive at Susquehanna. 2. Zosano Pharma (ZSAN) initiated with an Overweight at Cantor Fitzgerald. 3. Trade Desk (TTD) initiated with a Hold at Needham. 4. SQM (SQM) initiated with a Sell at Vertical Group. 5. Lyft (LYFT) initiated with an Outperform at JMP Securities, Raymond James, Cowen, and Credit Suisse, an Overweight at JPMorgan and Piper Jaffray, a Buy at Jefferies, Canaccord, and Stifel, and a Sector Weight at KeyBanc. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
JMIA Jumia Technologies
$35.31

-1.19 (-3.26%)

05/07/19
BREN
05/07/19
INITIATION
Target $45
BREN
Hold
Jumia Technologies initiated with a Hold at Berenberg
Berenberg initiated Jumia Technologies with a Hold and $45 price target.
05/07/19
MSCO
05/07/19
INITIATION
Target $27
MSCO
Underweight
Jumia Technologies initiated with an Underweight at Morgan Stanley
Morgan Stanley analyst Brian Nowak started Jumia Technologies with an Underweight rating and $27 price target, stating that he acknowledges Jumia opportunity with its 4M active buyer base representing only about 1% penetration of Africa's addressable smartphone user base. However, he believes the company's low buyer retention rates mean the company needs large investment and strong execution to grow, noting that he estimates only 50% of current active buyers return over the next 12 months. Nowak also contends that the stock's current valuation understates the risks and uncertainties facing Jumia, he tells investors.
05/07/19
WBLR
05/07/19
INITIATION
WBLR
Market Perform
Jumia Technologies initiated with a Market Perform at William Blair
William Blair analyst Ralph Schackart initiated Jumia Technologies with a Market Perform rating.
05/07/19
RAJA
05/07/19
INITIATION
RAJA
Market Perform
Jumia Technologies initiated with a Market Perform at Raymond James
Raymond James analyst Aaron Kessler started Jumia Technologies with a Market Perform rating, stating that while he expects robust e-commerce growth in Africa and thinks Jumia has significant potential beyond its core marketplaces, he also believes shares are fairly valued after advancing 170% from their IPO price of $14.50.
TXN Texas Instruments
$113.70

-0.71 (-0.62%)

05/07/19
NOMU
05/07/19
INITIATION
Target $106
NOMU
Neutral
Texas Instruments initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst David Wong started Texas Instruments with a Neutral rating and $106 price target. The analyst expects the company's trend of returning capital capital to holders via share repurchases and dividends to continue.
04/30/19
RBCM
04/30/19
INITIATION
Target $124
RBCM
Sector Perform
Texas Instruments assumed with a Sector Perform at RBC Capital
RBC Capital analyst Mitch Steves assumes Texas Instruments with an Sector Perform rating and a price target of $124, noting that the current demand checks suggest a "difficult period" for its analog sector. The analyst prefers "memory/5G/GPU investments" in the space, even though he is positive on Texas Instruments' expected mid-high single digit growth, market share gains, and margin expansion.
04/24/19
LOOP
04/24/19
NO CHANGE
Target $126
LOOP
Buy
Texas Instruments price target raised to $126 from $120 at Loop Capital
Loop Capital analyst Cody Acree raised his price target on Texas Instruments to $126 after a "mixed" Q1 performance. The analyst points to its "solid" sales / earnings beat and a below-consensus outlook for Q2, along with "cautious" commentary around continued slower annual demand. Acree is keeping his Buy rating on Texas Instruments however, saying the recent improvement in economic data from U.S. and China is reducing the macro related uncertainty, while the talks between the countries are giving some optimism toward the resolution of their trade tensions. The analyst further cites the potential benefits coming to Texas Instruments from the telecom transition to 5G equipment.
04/17/19
LBOW
04/17/19
DOWNGRADE
LBOW
Neutral
Longbow downgrades Texas Instruments, three other semis to Neutral
Longbow analyst Shawn Harrison downgraded Diodes (DIOD), ON Semiconductor (ON), Littelfuse (LFUS) and Texas Instruments (TXN) to Neutral from Buy to reflect a more conservative view of Q2 and second half sales growth relative to consensus expectations. Recent channel checks provided a more cautious view into any recovery given uncertainty in bookings in China and Europe, greater excess inventory than previously realized, and a return of semi pricing pressure, Harrison tells investors in a research note. Valuations also play a role in his downgrades of Littelfuse, Texas Instruments. For Diodes and ON Semiconductor, Harrison believes the slower demand recovery and a return of price declines will "mute clear secular tailwinds and weigh on sentiment, limiting upside."
TSM TSMC
$43.67

-0.1 (-0.23%)

02/04/19
SBSH
02/04/19
NO CHANGE
SBSH
Texas Instruments, TSMC, Lam among Citi's top global Semi picks for 2019
Citi's global top picks in Semiconductors are Texas Instruments (TXN), TSMC (TSM), Sony (SNE), Samsung (SSNLF), ASML (ASML), and Lam Research (LRCX), analysts led by Christopher Danely tell investors in a research note. Citi is "becoming more constructive as fundamentals are bottoming and semis are shipping below demand." The firm expects revenue for the Semiconductor sector in 2019 to decline 7% year-over-year, down from 15% year-over-year growth in 2018, due to the "memory crash dragging down overall sales." If China goes into recession, Citi believes semis will see "another big leg down." If not, the firm expects upside in the second half of 2019.
05/07/19
GSCO
05/07/19
INITIATION
Target $50
GSCO
Buy
TSMC initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Bruce Lu initiated TSMC with a Buy and $50 price target telling investors he expects the next phase of growth to come from innovations such as 5G and the expansion of high-performance computing.
04/18/19
DAIW
04/18/19
DOWNGRADE
DAIW
Outperform
TSMC downgraded to Outperform from Buy at Daiwa
04/10/19
DADA
04/10/19
NO CHANGE
Target $21
DADA
Buy
FormFactor price target raised to $21 from $18 at DA Davidson
DA Davidson analyst Thomas Diffely raised his price target on FormFactor (FORM) to $21 and kept his Buy rating after meeting with its management at an investor event last week. The analyst says investors were "pleasantly surprised" by the stability of the company's "design driven model" during industry slowdowns, adding that he sees FormFactor's "unique business drivers" being "larger then expected". Diffely further cites a potential revenue recovery at Intel (INTC), continued revenue growth at TSMC (TSM), and ramping activity from 5G and photonic" markets in concluding that FormFactor's growth prospects look "increasingly bullish".

TODAY'S FREE FLY STORIES

AVP

Avon Products

$3.20

0.06 (1.91%)

05:45
05/22/19
05/22
05:45
05/22/19
05:45
Periodicals
Avon Products nearing sale to Brazil's Natura, WSJ reports »

Avon Products (AVP) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$169.62

1.26 (0.75%)

05:41
05/22/19
05/22
05:41
05/22/19
05:41
Hot Stocks
Amgen announces recommended public cash offer to the shareholders of Nuevolution »

Amgen announces a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

NVS

Novartis

$82.38

0.36 (0.44%)

05:38
05/22/19
05/22
05:38
05/22/19
05:38
Hot Stocks
Novartis: QVM149 phase II data shows improvements over current standard-of-care »

Novartis announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    May

HALO

Halozyme

$15.60

0.385 (2.53%)

05:25
05/22/19
05/22
05:25
05/22/19
05:25
Hot Stocks
Halozyme says argenx selected 2nd target under collaboration, license agreement »

Halozyme Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 31

    May

LM

Legg Mason

$36.89

1.21 (3.39%)

05:24
05/22/19
05/22
05:24
05/22/19
05:24
Upgrade
Legg Mason rating change  »

Legg Mason upgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SE

Sea Limited

$25.38

-0.42 (-1.63%)

05:16
05/22/19
05/22
05:16
05/22/19
05:16
Recommendations
Sea Limited analyst commentary at Piper Jaffray »

Sea Limited price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$260.47

7.89 (3.12%)

05:13
05/22/19
05/22
05:13
05/22/19
05:13
Recommendations
Abiomed analyst commentary  »

Abiomed 20% selloff this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

ABMD

Abiomed

$260.47

7.89 (3.12%)

05:10
05/22/19
05/22
05:10
05/22/19
05:10
Hot Stocks
Abiomed says FDA confirmed Impella RP heart pump is 'safe and effective' »

Abiomed yesterday …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

ABMD

Abiomed

$260.47

7.89 (3.12%)

05:08
05/22/19
05/22
05:08
05/22/19
05:08
Hot Stocks
FDA says benefits of Impella RP system continue to outweigh risks »

The FDA told doctors in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

FLIR

Flir Systems

$49.66

0.65 (1.33%)

05:02
05/22/19
05/22
05:02
05/22/19
05:02
Upgrade
Flir Systems rating change  »

Flir Systems upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 27

    Jun

TMDI

Titan Medical

$2.70

0.2 (8.00%)

04:59
05/22/19
05/22
04:59
05/22/19
04:59
Initiation
Titan Medical initiated at Piper Jaffray »

Titan Medical initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRXC

TransEnterix

$1.27

-0.03 (-2.32%)

04:57
05/22/19
05/22
04:57
05/22/19
04:57
Initiation
TransEnterix initiated at Piper Jaffray »

TransEnterix initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
05/22/19
05/22
04:55
05/22/19
04:55
General news
Breaking General news story  »

Week of 5/17 MBA Mortgage…

PFG

Principal Financial

$55.31

0.41 (0.75%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Principal Financial Group participates in a conference call with JPMorgan »

Life Insurance Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 11

    Jun

  • 26

    Jul

STML

Stemline

$15.07

0.71 (4.94%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Stemline management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    May

ARKAY

Arkema

$0.00

(0.00%)

, AVT

Avnet

$43.94

0.84 (1.95%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Lightfair International to hold a conference »

Lightfair 2019…

ARKAY

Arkema

$0.00

(0.00%)

AVT

Avnet

$43.94

0.84 (1.95%)

CREE

Cree

$58.84

1.41 (2.46%)

ETN

Eaton

$79.88

1.39 (1.77%)

IKTSY

Intertek

$0.00

(0.00%)

ITRI

Itron

$57.78

1.21 (2.14%)

ORCL

Oracle

$54.18

0.54 (1.01%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 04

    Jun

  • 10

    Jun

  • 20

    Aug

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Credit Suisse U.S. strategist team to hold an analyst/industry conference call »

The U.S. Sector…

MED

Medifast

$146.66

1.35 (0.93%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Medifast management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 12

    Jun

EXTR

Extreme Networks

$6.15

0.11 (1.82%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
JPMorgan telecom/IT hardware analyst to hold an analyst/industry conference call »

Telecom & IT Hardware…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 28

    May

  • 30

    May

BANR

Banner Corp.

$53.76

-0.04 (-0.07%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Banner Corp. management to meet with Sandler ONeill »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

CHD

Church & Dwight

$73.99

-0.02 (-0.03%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Church & Dwight management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

MSM

MSC Industrial

$75.80

0.57 (0.76%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
MSC Industrial management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 24

    May

  • 05

    Jun

  • 13

    Nov

KLIC

Kulicke & Soffa

$19.35

0.19 (0.99%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Kulicke & Soffa management to meet with Craig-Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

CINF

Cincinnati Financial

$99.25

1.07 (1.09%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Cincinnati Financial management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

JAZZ

Jazz Pharmaceuticals

$139.92

1.49 (1.08%)

04:55
05/22/19
05/22
04:55
05/22/19
04:55
Conference/Events
Jazz Pharmaceuticals management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 31

    May

  • 05

    Jun

  • 23

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.